Mobile

A randomised, double-blind, placebo-controlled, three-way crossover, repeat dose pilot study comparing the effect of inhaled fluticasone furoate/GW642444M combination and fluticasone furoate on the al...

Mise à jour : Il y a 5 ans
Référence : EUCTR2009-016581-80

A randomised, double-blind, placebo-controlled, three-way crossover, repeat dose pilot study comparing the effect of inhaled fluticasone furoate/GW642444M combination and fluticasone furoate on the allergen-induced early asthmatic response in subjects with mild asthma

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To evaluate the bronchoprotective effect of treatment with repeat inhaled doses of inhaled fluticasone furoate(GW685698)/GW642444M combination 100mcg/25 mcg and fluticasone furoate 100mcg on the early asthmatic response (EAR) to inhaled allergen at 22-23 hours post-dose in mild asthmatic subjects compared with placebo

Critère d'inclusion

  • Asthma

Liens